Home > Quotes > JNJ > Company News

Johnson & Johnson News Headlines

JNJ 
$86.82
*  
0.39
  negative  
0.45%
Get JNJ Alerts
*Delayed - data as of May 24, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

FDA Clears Covidien's Exalgo Tablet - Analyst Blog
8/28/2012 12:34:25 PM - Zacks.com

DexCom Remains Neutral - Analyst Blog
8/27/2012 11:32:32 AM - Zacks.com

Hansen Medical Boosts IP Portfolio - Analyst Blog
8/24/2012 4:32:49 PM - Zacks.com

Glaxo-JNJ Candidate in Phase III - Analyst Blog
8/24/2012 4:23:01 PM - Zacks.com

Pharmacyclics Earns Milestone - Analyst Blog
8/24/2012 3:33:06 PM - Zacks.com

Slew of Product Recalls at Covidien - Analyst Blog
8/24/2012 2:32:47 PM - Zacks.com

Bard Remains Neutral - Analyst Blog
8/23/2012 1:32:35 PM - Zacks.com

Good News for Alexza Pharma - Analyst Blog
8/23/2012 10:32:39 AM - Zacks.com

The Safest Dividend Stocks In The S&P 500
8/23/2012 9:00:00 AM - Amy Calistri

FDA Extends PFE Drug Review Period - Analyst Blog
8/22/2012 3:30:01 PM - Zacks.com

Dividend ETFs: Here’s One Delivering High Yield Without a Risky Utility Bet -- its 5 Top Stocks
8/21/2012 3:44:17 PM - YCHARTS

Covidien Backs Safe Use of Opioid - Analyst Blog
8/17/2012 6:21:34 PM - Zacks.com

What's Warren Buffett’s Buying -- and Selling -- These Days?
8/16/2012 12:56:57 PM - YCHARTS

Time For Investors To Take Back Our Streets. Here's How
8/15/2012 11:52:01 PM - SeekingAlpha

Elan to Split into Two Companies - Analyst Blog
8/14/2012 10:23:13 AM - Zacks.com

Covidien Remains Neutral Post-Earnings - Analyst Blog
8/13/2012 4:37:01 PM - Zacks.com

Johnson & Johnson: A Buy And Core Holding For The Long Haul
8/9/2012 2:57:07 PM - SeekingAlpha

Stryker Remains Neutral - Analyst Blog
8/8/2012 5:22:52 PM - Zacks.com

Onyx Loss up on Wider Costs - Analyst Blog
8/8/2012 9:15:01 AM - Zacks.com

Decision Date for Medivation Drug - Analyst Blog
8/7/2012 6:22:21 PM - Zacks.com

Pfizer & JNJ End Bapineuzumab IV - Analyst Blog
8/7/2012 3:21:17 PM - Zacks.com

DexCom Misses on EPS, Losses Climb - Analyst Blog
8/7/2012 10:21:48 AM - Zacks.com

Covidien Opens R&D Base in China - Analyst Blog
8/6/2012 6:21:47 PM - Zacks.com

Why Bill Gross Hating Stocks – but Hating Bonds More – Leads Us Back to Stocks, and Dividends
8/6/2012 8:31:55 AM - YCHARTS

SurModics Beats on All Fronts - Analyst Blog
8/3/2012 3:22:37 PM - Zacks.com